Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study.
about
Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan AfricaKaposi Sarcoma among HIV Infected Patients in Lagos University Teaching Hospital, Nigeria: A 14-Year Retrospective Clinicopathological Study.Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia.Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.The placental specific gene, PLAC1, is induced by the Epstein-Barr virus and is expressed in human tumor cellsKaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversionChanging patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.AIDS related systemic non-Hodgkin's lymphomaAcquired immunodeficiency syndrome-related systemic non-Hodgkin's lymphoma.Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.Management of protozoal diarrhoea in HIV disease.EBV and HIV-Related LymphomaWeekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.A preliminary investigation of ADHD symptoms in persons with celiac disease.Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings.Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.The tumor virus landscape of AIDS-related lymphomasOral Kaposi sarcoma associated with severe alveolar bone loss: case report and review of the literature.Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South AfricaRituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings.Therapy of other viral infections: herpes to hepatitis.Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons.Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settingsCurrent trends of HIV disease of the mouth.AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.The risk of cancer in HIV-infected people in southeast England: a cohort studyThe non-Hodgkin lymphomas: a review of the epidemiologic literature.Epidemiology, pathogenesis, and management of human immunodeficiency virus infection in patients with periodontal disease.Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UK.Malignancies in women with HIV infection.Spectrum of AIDS defining & non-AIDS defining malignancies in north IndiaClassification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition.Resistance to TRAIL and how to surmount it.Targeting endoplasmic reticulum signaling pathways in cancer.
P2860
Q30386031-D7CE32D7-6674-48A5-91DD-949198E1E80AQ30386336-7452ACD4-8ACB-4081-8A54-33BC99606AF3Q33341768-CF0343CA-517C-4EA5-AB32-532940AE06B4Q33491795-A9CA193B-96B7-4CCA-BD63-8E7F7B25729BQ33812158-73BFDB64-B1CD-4506-9056-B61EC04ADD87Q33888845-94A54504-DDC5-410E-A8E1-32736C16929EQ34059657-92FD675B-67D4-414C-97B6-C1284EDA644AQ34120667-5F21113B-8774-4169-B371-DB8D66950164Q34216501-22140C5A-8E56-4352-9057-072F217658B0Q34403321-E88B0D5C-CB3E-485F-AE5A-FFFC09EE76ACQ34459304-F44A3431-4FD9-495F-B9B7-96EF55F869C3Q34549450-FE058CA8-0614-42E5-BF4A-2713D6D63557Q34553105-637540C6-D2C7-4FCF-BF6C-56ADE51A2E21Q34579401-A5399906-3708-4C7C-83EA-57E1B47785EAQ34637897-35F32F9A-4912-43AF-97B7-0B12AE724EDFQ34644229-1A2483CB-281F-40E8-A8AF-241A4AAEE425Q34952990-D7E3FE76-F87A-4DC5-AF77-0D685541BA67Q35557475-C88B1D46-755B-412A-ADB3-88BB901FD8DBQ35607311-B0F8E2B8-D0C8-4D0A-854B-E02764A4D1B1Q35610434-C84E7850-7B8A-4044-AC1B-B3105DEF9334Q35632074-86F2D8E4-5F38-4E2E-88D8-87C24E2FB3DEQ35848116-69E0E7F4-6D06-4E85-882F-4C88A05E3658Q35884800-E13F1760-5E59-464E-B5CB-FCB1CC261557Q35967424-3B8D1A32-2309-4D33-9A57-8EEE2533E51CQ36036666-B7455847-7D3B-474D-94A3-ADD91BB926C9Q36088274-7B61F3BE-4B8A-4D1B-A3E1-841CFCEF2D95Q36162341-BFFE6651-8EAA-4891-8001-713370AEC684Q36247417-382400DA-32E9-429C-A29A-7E6D7E5D659CQ36268446-5C9E0D54-67D5-4C7F-A51A-46A064AEFBCEQ36456737-A271E93B-8048-4B96-98EE-D62F23CAC8ABQ36615747-9A457C89-6945-4BCF-8482-7B3DC5FBC89AQ36778875-EFA1B08C-9A96-432A-8C49-8507B97842D5Q36809170-C918F7E4-557A-450D-9DEB-FEC136E8805DQ36859148-4962EE5D-FA34-46FE-B1ED-505CA854B686Q37207800-DCA6583B-9CF8-4776-9E83-C5BB349B9E50Q37346149-2BAB7989-2718-4D1B-A60E-A7187BE9C955Q37367685-8A71BC9F-50F0-4BB9-8999-C5DD61BEDE97Q37595265-427BE9B1-C601-4011-A239-6073D00E29AAQ37992546-DC66E6EA-D2A6-49A7-A720-A2D826E4A7F4Q38017716-5C009813-C5D7-45F1-B920-E584EC061040
P2860
Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Risk of HIV related Kaposi's s ...... study. Swiss HIV Cohort Study.
@en
type
label
Risk of HIV related Kaposi's s ...... study. Swiss HIV Cohort Study.
@en
prefLabel
Risk of HIV related Kaposi's s ...... study. Swiss HIV Cohort Study.
@en
P2093
P2860
P356
P1433
P1476
Risk of HIV related Kaposi's s ...... study. Swiss HIV Cohort Study.
@en
P2093
P2860
P356
10.1136/BMJ.319.7201.23
P407
P577
1999-07-01T00:00:00Z